Search research articles
Contact Us
Filters
Showing results (1-10 of 75) with videos related to
Page
of 8
Sort By:
Journal of Alzheimer'S Disease : JAD
|
September 25, 2015
Differential Expression of microRNA in Cerebrospinal Fluid as a Potential Novel Biomarker for Alzheimer's Disease
Argonde C van Harten, Joyce Mulders, Philip Scheltens, et al.
Neurobiology of Aging
|
June 3, 2017
CSF ApoE predicts clinical progression in nondemented APOEε4 carriers
Argonde C van Harten, Wesley Jongbloed, Charlotte E Teunissen, et al.
Stroke
|
July 16, 2015
White Matter Hyperintensities Relate to Clinical Progression in Subjective Cognitive Decline
Marije R Benedictus, Argonde C van Harten, Annebet E Leeuwis, et al.
Clinical Chemistry and Laboratory Medicine
|
February 24, 2011
Tau and p-tau as CSF biomarkers in dementia: a meta-analysis
Argonde C van Harten, Maartje I Kester, Pieter-Jelle Visser, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 13, 2012
Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaints
Argonde C van Harten, Pieter Jelle Visser, Yolande A L Pijnenburg, et al.
Neurology
|
September 20, 2013
Preclinical AD predicts decline in memory and executive functions in subjective complaints
Argonde C van Harten, Lieke L Smits, Charlotte E Teunissen, et al.
Annals of Clinical and Translational Neurology
|
September 26, 2018
Pre-amyloid stage of Alzheimer's disease in cognitively normal individuals
Betty M Tijms, Lisa Vermunt, Marissa D Zwan, et al.
Brain : a Journal of Neurology
|
July 18, 2025
CSF proteomic profiles related to cognitive decline in MCI A+ depend on tau levels
Eleonora M Vromen, Diederick M de Leeuw, Argonde C van Harten, et al.
Neuroimage. Clinical
|
April 23, 2025
Individualized lesion-symptom mapping using explainable artificial intelligence for the cognitive impact of white matter hyperintensities
Ryanne Offenberg, Alberto De Luca, Geert Jan Biessels, et al.
Journal of Alzheimer'S Disease : JAD
|
December 31, 2016
Apolipoprotein A1 in Cerebrospinal Fluid and Plasma and Progression to Alzheimer's Disease in Non-Demented Elderly
Rosalinde E R Slot, Argonde C Van Harten, Maartje I Kester, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 75) with videos related to
Sort By:
Page
of 8
Journal of Alzheimer'S Disease : JAD
|
September 25, 2015
Differential Expression of microRNA in Cerebrospinal Fluid as a Potential Novel Biomarker for Alzheimer's Disease
Argonde C van Harten, Joyce Mulders, Philip Scheltens, et al.
Neurobiology of Aging
|
June 3, 2017
CSF ApoE predicts clinical progression in nondemented APOEε4 carriers
Argonde C van Harten, Wesley Jongbloed, Charlotte E Teunissen, et al.
Stroke
|
July 16, 2015
White Matter Hyperintensities Relate to Clinical Progression in Subjective Cognitive Decline
Marije R Benedictus, Argonde C van Harten, Annebet E Leeuwis, et al.
Clinical Chemistry and Laboratory Medicine
|
February 24, 2011
Tau and p-tau as CSF biomarkers in dementia: a meta-analysis
Argonde C van Harten, Maartje I Kester, Pieter-Jelle Visser, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 13, 2012
Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaints
Argonde C van Harten, Pieter Jelle Visser, Yolande A L Pijnenburg, et al.
Neurology
|
September 20, 2013
Preclinical AD predicts decline in memory and executive functions in subjective complaints
Argonde C van Harten, Lieke L Smits, Charlotte E Teunissen, et al.
Annals of Clinical and Translational Neurology
|
September 26, 2018
Pre-amyloid stage of Alzheimer's disease in cognitively normal individuals
Betty M Tijms, Lisa Vermunt, Marissa D Zwan, et al.
Brain : a Journal of Neurology
|
July 18, 2025
CSF proteomic profiles related to cognitive decline in MCI A+ depend on tau levels
Eleonora M Vromen, Diederick M de Leeuw, Argonde C van Harten, et al.
Neuroimage. Clinical
|
April 23, 2025
Individualized lesion-symptom mapping using explainable artificial intelligence for the cognitive impact of white matter hyperintensities
Ryanne Offenberg, Alberto De Luca, Geert Jan Biessels, et al.
Journal of Alzheimer'S Disease : JAD
|
December 31, 2016
Apolipoprotein A1 in Cerebrospinal Fluid and Plasma and Progression to Alzheimer's Disease in Non-Demented Elderly
Rosalinde E R Slot, Argonde C Van Harten, Maartje I Kester, et al.
Page
of 8